Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Baxter confirms Adept ‘effective’ in reducing adhesions

Baxter confirms Adept ‘effective’ in reducing adhesions

2nd November 2007

Baxter International and Vectura Group have confirmed that trials of its Adept Adhesion Reduction Solution showed it to be more effective than lactated Ringer’s solution (LRS) in reducing adhesions in patients undergoing gynaecological laparoscopic adhesiolysis.

Study results, published in the November 2007 issue of Fertility and Sterility, referred to one of the largest adhesion reduction agent trials ever performed, with Baxter’s Adept being compared to LRS in gynaecological laparoscopic surgery.

As well as being shown to reduce adhesions more effectively than LRS, Adept was also found to be safe and in particular demonstrated efficacy in infertility patients.

Ron Lloyd, vice president of Baxter’s BioTherapeutics and Regenerative Medicine business, described how adhesions can take several days to form following surgery.

“Other solutions used, although not approved, for adhesion reduction during laparoscopic gynaecological surgery are absorbed within hours, reducing their effectiveness in preventing adhesions.”

He went on to illustrate how Adept formed a fluid reservoir in the peritoneal cavity which resides during the critical period of adhesion formation and so can separate and minimise contact between organs.

Earlier this month, Baxter announced its financial results for the third quarter of 2007, with the company announcing “strong” figures and consequently raising its financial outlook for the full year for the third successive quarter.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.